Recombinant Proteins
Recombinant proteins are central to modern biopharmaceutical research and manufacturing, underpinning therapies, diagnostics, and vaccines worldwide. Produced through recombinant DNA technology, these proteins must undergo precise purification to remove host cell proteins, nucleic acids, aggregates, and other process-related impurities, ensuring safety, efficacy, and consistency.
Chromatography remains the gold standard for recombinant protein purification, delivering the selectivity and robustness required to achieve demanding purity and yield targets. By enhancing process efficiency and reproducibility, it plays a pivotal role in accelerating the path from discovery to commercialisation.
At Astrea Bioseparations, we design chromatography resins specifically for critical recombinant protein workflows. Our high-capacity, high-selectivity solutions are optimised for both capture and polishing, enabling the concentration of target biomolecules and the precise removal of impurities. With innovative chemistries and proven scalability, our technologies empower the biopharmaceutical industry to deliver safe, effective, and life-changing therapies.